FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

Gardasil related Press Releases

Studies of GARDASIL, Merck's Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at Conference

Posted May 11, 2009

Studies of GARDASIL, Merck's Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at International Papillomavirus Conference

Data from an Extension of a Phase II Study

... Read more...

Merck & Co., Inc. Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL in Older Women

Posted January 9, 2009

Merck & Co., Inc. Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL® in Women Ages 27 through 45

WHITEHOUSE STATION, N.J., Jan. 9, 2009 -

... Read more...

Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study

Posted November 13, 2008

Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study Pivotal Study Evaluating Efficacy of GARDASIL in Males in Preventing HPV

... Read more...

FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers

Posted September 15, 2008

FDA Approves Expanded Uses for Gardasil to Include Preventing Certain Vulvar and Vaginal Cancers September 12, 2008 The U.S. Food and Drug Administration today announced the approval of the vaccine... Read more...

PRESS RELEASE: Merck's GARDASIL and JANUVIA Receive Prix Galien USA Top Honors

Posted October 4, 2007

Merck's GARDASIL and JANUVIA Receive Prix Galien USA Top Honors Merck Products Named Best Biotechnology Product and Best Pharmaceutical Agent Former Merck CEO P. Roy Vagelos, M.D., Receives Pro Bono... Read more...